Monthly Archives: August 2020

Gilead seeks FDA approval for COVID-19 drug inhibitor

Gilead Sciences on Monday applied for approval from the U.S. Food and Drug Administration for its COVID-19 treatment, remdesivir. The biotech company also said the antiviral drug will go by the Veklury brand name in the US “Submitting today is a major milestone as we continue to work with the …

Read More »